Capital expenditure increased 343.4%
Capital expenditure changed +343.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$22.8M→$101.1M4 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +343.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +88.9% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.